Stockscreener 앱 받기
34.35
1.24%
-0.43
시간 외 거래:
34.05
-0.30
-0.87%
전일 마감가:
$34.78
열려 있는:
$34.78
하루 거래량:
4.24M
Relative Volume:
0.58
시가총액:
$3.07B
수익:
$288.07M
순이익/손실:
$22.31M
주가수익비율:
242.58
EPS:
0.1416
순현금흐름:
$41.15M
1주 성능:
+25.46%
1개월 성능:
-49.82%
6개월 성능:
-17.03%
1년 성능:
+48.19%
1일 변동 폭
$33.33
$34.90
1주일 범위
$26.13
$38.64
52주 변동 폭
$21.94
$93.61
Liquidia Corp Stock (LQDA) Company Profile
명칭
Liquidia Corp
전화
919.328.4400
주소
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Compare LQDA vs TAK, TEVA, HLN, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
34.35 | 3.07B | 288.07M | 22.31M | 41.15M | 0.1416 |
TAK
Takeda Pharmaceutical Co Adr
|
19.67 | 62.84B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.50 | 48.40B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
10.13 | 44.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
79.38 | 32.80B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
533.12 | 22.87B | 3.17B | 1.29B | 1.01B | 27.09 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-10-14 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2026-10-02 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2026-10-01 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2026-10-01 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2026-06-29 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-10-20 | 개시 | Wells Fargo | Overweight |
| 2025-08-15 | 재개 | Jefferies | Buy |
| 2025-05-19 | 다운그레이드 | Oppenheimer | Perform → Underperform |
| 2024-12-20 | 개시 | Wells Fargo | Overweight |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-08-19 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-08-16 | 개시 | Raymond James | Outperform |
| 2024-06-25 | 개시 | Oppenheimer | Perform |
| 2024-01-05 | 재확인 | Needham | Buy |
| 2022-09-19 | 재개 | Wedbush | Underperform |
| 2022-09-01 | 다운그레이드 | Wedbush | Neutral → Underperform |
| 2022-07-22 | 개시 | Ladenburg Thalmann | Buy |
| 2022-05-31 | 개시 | BTIG Research | Buy |
| 2022-05-26 | 개시 | BofA Securities | Buy |
| 2020-12-04 | 개시 | H.C. Wainwright | Buy |
| 2020-11-20 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2018-11-08 | 재개 | Jefferies | Buy |
| 2018-09-05 | 개시 | Wedbush | Outperform |
| 2018-08-20 | 개시 | Jefferies | Buy |
| 2018-08-20 | 개시 | Needham | Buy |
모두보기
Liquidia Corp 주식(LQDA)의 최신 뉴스
LQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia Label - Zacks Investment Research
Liquidia CBO Jason Adair sells $207,932 in shares after vesting - Investing.com
Liquidia Corp general counsel Schundler sells $389,948 of stock - Investing.com
Liquidia CCO Scott Moomaw sells $252,418 in company stock By Investing.com - Investing.com India
To cover stock-award taxes, Liquidia (LQDA) general counsel sells 13,692 shares at $28.48 each. - Stock Titan
Scott Moomaw Disposes 8,863 Shares of Liquidia Corp (LQDA) Following PSU Vesting on October 12, 2026 - Kalkine Media
Liquidia Corp's Rajeev Saggar Converts PSUs and Sells 9,218 Shares on October 12, 2026 - Kalkine Media
Liquidia Corp CBO Jason Adair Sells 7,301 Shares at $28.48 Following RSU and PSU Vesting in October 2026 - Kalkine Media
To cover stock-award taxes, Liquidia (LQDA) CFO and COO Kaseta sold 18,938 shares at $28.48 each. - Stock Titan
A tax-related sale at Liquidia (LQDA) totals 1,101 shares at $28.48 each. - Stock Titan
To cover stock-award taxes, Liquidia (LQDA) CEO Roger Jeffs sold 32,744 shares. - Stock Titan
To cover award taxes, Dana Boyle sells 5,892 Liquidia (LQDA) shares at $28.48 each. - Stock Titan
Stephen M. Bloch Sells 235,477 Liquidia Shares via Canaan VIII L.P. at $27.13 Average Price - Kalkine Media
Liquidia director Stephen Bloch sells $6.39m in shares - Investing.com
LIQUIDIA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Liquidia Corporation on Behalf of Liquidia Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Liquidia Stock Plunges 57% on UTHR Patent Litigation Setback - Zacks Investment Research
UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13% - Zacks Investment Research
Liquidia Corporation (LQDA) Stock Price & News - Syfe
Option exercises and share sales by Liquidia (NASDAQ: LQDA) director - Stock Titan
Liquidia (NASDAQ:LQDA) Rating Lowered to "Hold" at Wall Street Zen - MarketBeat
Director at Liquidia (NASDAQ: LQDA) plans $619K stock sale - Stock Titan
LQDA Loses 13.9% in a Month: Should Investors Avoid the Stock Now? - Yahoo Finance
Liquidia Corporation $LQDA Holdings Decreased by Opaleye Management Inc. - MarketBeat
Can a Potential Label Expansion of Yutrepia Boost LQDA's Portfolio? - Yahoo Finance
What Could Put Liquidia (NASDAQ:LQDA) On A New Path? - Kalkine Media
LQDA - Finviz
LQDA - Finviz
LIQUIDIA CORP (NASDAQ:LQDA) Fits the Affordable Growth Screen - ChartMill
Liquidia at Wells Fargo 21st annual healthcare conference: growth and pipeline - Investing.com India
Liquidia at Wells Fargo 21st annual healthcare conference: growth and pipeline - Investing.com
Liquidia at Wells Fargo 21st annual healthcare conference: growth and pipeline - Investing.com UK
Wellington Management Group LLP Sells 22,925 Shares of Liquidia Corporation $LQDA - MarketBeat
Liquidia Corp Stock Intrinsic Values - GuruFocus
Does FDA Fast Track For YUTREPIA In SSc Raynaud’s Change The Bull Case For Liquidia (LQDA)? - Yahoo Finance
Is Liquidia (LQDA) Still Undervalued As Fast Track News Tests Its Valuation? - Yahoo Finance
Liquidia (LQDA) Stock Looks Stretched On Earnings But Reasonable On Broader Checks - Yahoo Finance
Liquidia Corp CHRO Sarah Krepp Sells 274 Shares Under Pre-Set 10b5-1 Trading Plan - kalkinemedia.com
Liquidia Corp (NASDAQ: LQDA) Secures FDA Fast Track for YUTREPIA Targeting Raynaud’s Phenomenon in Up to 90% of Systemic Sclerosis Patients - Kalkine Media
How Does Liquidia Corporation's (NASDAQ:LQDA) PRINT Platform Actually Work? - Kalkine Media
Why Is Liquidia Stock Gaining Thursday?Liquidia (NASDAQ:LQDA) - Benzinga
Liquidia Corporation’s (LQDA) Yutrepia Launch Continues to Outpace the Expectations - Yahoo Finance
LQDA Looks 75.0% Undervalued on GF Value™ - GuruFocus
Liquidia’s YUTREPIA Receives FDA Fast Track Designation for Systemic Sclerosis-Associated Raynaud’s Phenomenon - Quiver Quantitative
Liquidia Gets FDA Fast Track for YUTREPIA Raynaud's | LQDA Stock News - Stock Titan
Liquidia Corporation $LQDA Shares Sold by Pale Fire Capital SE - MarketBeat
Liquidia Corporation (NASDAQ:LQDA) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Liquidia Corp (LQDA) Shares Surge 4.1% -- What GF Score of 70 Te - GuruFocus
Liquidia to Present Posters at the European Respiratory Society (ERS) 2026 Congress - finance.yahoo.com
Two lung-disease studies will be presented in Barcelona - Stock Titan
Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference - The Manila Times
Liquidia Corp (LQDA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Liquidia Corp 주식 (LQDA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Adair Jason | Chief Business Officer |
Oct 12 '26 |
Sale |
28.48 |
7,301 |
207,932 |
177,957 |
| Khindri Sanjeev | Chief Development Officer |
Oct 12 '26 |
Sale |
28.48 |
1,101 |
31,356 |
64,846 |
| Kaseta Michael | CFO and COO |
Oct 12 '26 |
Sale |
28.48 |
18,938 |
539,354 |
340,148 |
| JEFFS ROGER | Chief Executive Officer |
Oct 12 '26 |
Sale |
28.48 |
32,744 |
932,549 |
1,125,848 |
| Boyle Dana | Chief Accounting Officer |
Oct 12 '26 |
Sale |
28.48 |
5,892 |
167,804 |
165,609 |
| Saggar Rajeev | Chief Medical Officer |
Oct 12 '26 |
Sale |
28.48 |
9,218 |
262,529 |
126,368 |
| Moomaw Scott | Chief Commercial Officer |
Oct 12 '26 |
Sale |
28.48 |
8,863 |
252,418 |
181,487 |
| Krepp Sarah | Chief Human Resource Officer |
Oct 12 '26 |
Sale |
28.48 |
5,245 |
149,378 |
115,241 |
| Bloch Stephen M | Director |
Oct 05 '26 |
Sale |
27.13 |
235,477 |
6,387,596 |
0 |
| SINGH RAMAN | Director |
Sep 14 '26 |
Option Exercise |
9.31 |
8,468 |
78,799 |
53,105 |
4.74%
0.79%
자본화:
|
볼륨(24시간):